EKF Diagnostics Holdings PLC
LSE:EKF
EKF Diagnostics Holdings PLC
Common Shares Outstanding
EKF Diagnostics Holdings PLC
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Common Shares Outstanding
£453.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
Smith & Nephew PLC
LSE:SN
|
Common Shares Outstanding
$871.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Common Shares Outstanding
$54.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Common Shares Outstanding
$164.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Common Shares Outstanding
£260.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Common Shares Outstanding
£361.3m
|
CAGR 3-Years
30%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is EKF Diagnostics Holdings PLC's Common Shares Outstanding?
Common Shares Outstanding
453.7m
GBP
Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Common Shares Outstanding amounts to 453.7m GBP.
What is EKF Diagnostics Holdings PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
5%
Over the last year, the Common Shares Outstanding growth was 0%.